Penwest to Present At RBC Capital Markets Healthcare Conference
02 déc. 2008 09h00 HE
|
Penwest Pharmaceuticals Co.
DANBURY, Conn., Dec. 2, 2008 (GLOBE NEWSWIRE) -- Penwest Pharmaceuticals Co. (Nasdaq:PPCO) today announced that Jennifer Good, President and Chief Executive Officer of Penwest, will be presenting at...
Penwest Enters Into Second Research and Development Agreement With Otsuka Pharmaceutical
25 nov. 2008 08h00 HE
|
Penwest Pharmaceuticals Co.
DANBURY, Conn., Nov. 25, 2008 (GLOBE NEWSWIRE) -- Penwest Pharmaceuticals Co. (Nasdaq:PPCO) today announced that it has signed a second research and development agreement with Otsuka Pharmaceutical...
Penwest Reports Third Quarter 2008 Financial Results
04 nov. 2008 08h00 HE
|
Penwest Pharmaceuticals Co.
DANBURY, Conn., Nov. 4, 2008 (GLOBE NEWSWIRE) -- Penwest Pharmaceuticals Co. (Nasdaq:PPCO) today announced its financial results for the third quarter ended September 30, 2008. Overall, as compared to...
Penwest Third Quarter 2008 Financial Results Conference Call
21 oct. 2008 11h07 HE
|
Penwest Pharmaceuticals Co.
DANBURY, Conn., Oct. 21, 2008 (GLOBE NEWSWIRE) -- Penwest Pharmaceuticals Co. (Nasdaq:PPCO) will conduct a conference call on Tuesday, November 4th, at 11:00 a.m. EST to review its financial results...
Penwest Reports Second Quarter 2008 Financial Results
05 août 2008 08h00 HE
|
Penwest Pharmaceuticals Co.
DANBURY, Conn., Aug. 5, 2008 (PRIME NEWSWIRE) -- Penwest Pharmaceuticals Co. (Nasdaq:PPCO) today announced its financial results for the second quarter ended June 30, 2008. Overall, as compared to the...
Penwest Second Quarter 2008 Financial Results Conference Call
23 juil. 2008 08h30 HE
|
Penwest Pharmaceuticals Co.
DANBURY, Conn., July 23, 2008 (PRIME NEWSWIRE) -- Penwest Pharmaceuticals Co. (Nasdaq:PPCO) will conduct a conference call on Tuesday, August 5th, at 11:00 a.m. EDT to review its financial results for...
Penwest to Present At Two Upcoming Conferences
22 juil. 2008 11h53 HE
|
Penwest Pharmaceuticals Co.
DANBURY, Conn., July 22, 2008 (PRIME NEWSWIRE) -- Penwest Pharmaceuticals Co. (Nasdaq:PPCO) today announced that Ms. Jennifer L. Good, President and Chief Executive Officer, will be presenting at two...
Penwest Begins Phase Ia Clinical Trial of A0001, a Compound For Treatment of Mitochondrial Diseases
14 juil. 2008 08h30 HE
|
Penwest Pharmaceuticals Co.
DANBURY, Conn., July 14, 2008 (PRIME NEWSWIRE) -- Penwest Pharmaceuticals Co. (Nasdaq:PPCO) today announced that it has begun dosing in a Phase Ia clinical trial of A0001, a compound the Company is...
Penwest Begins Phase I Clinical Trial of PW 4153, Candidate For Treatment of Symptoms of Parkinson's Disease
10 juil. 2008 08h00 HE
|
Penwest Pharmaceuticals Co.
DANBURY, Conn., July 10, 2008 (PRIME NEWSWIRE) -- Penwest Pharmaceuticals Co. (Nasdaq:PPCO) today announced that it has begun dosing in a Phase I clinical trial of PW 4153, a drug candidate for the...
Penwest Enters Into Development and Licensing Agreement With Cobalt Laboratories
20 mai 2008 08h00 HE
|
Penwest Pharmaceuticals Co.
DANBURY, Conn., May 20, 2008 (PRIME NEWSWIRE) -- Penwest Pharmaceuticals Co. (Nasdaq:PPCO) today announced that it has signed a development and licensing agreement with Cobalt Laboratories Inc. to...